Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells.
about
Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Synergistic antitumor activity ...... ive human breast cancer cells.
@en
Synergistic antitumor activity ...... ive human breast cancer cells.
@nl
type
label
Synergistic antitumor activity ...... ive human breast cancer cells.
@en
Synergistic antitumor activity ...... ive human breast cancer cells.
@nl
prefLabel
Synergistic antitumor activity ...... ive human breast cancer cells.
@en
Synergistic antitumor activity ...... ive human breast cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Synergistic antitumor activity ...... ive human breast cancer cells.
@en
P2093
Ana Laura Martinez
Analía Lourdes Redondo
Angel Matias Sanchez
Fiorella Vanderhoeven
Laura María Vargas-Roig
Marina Inés Flamini
P2860
P304
26527-26542
P356
10.18632/ONCOTARGET.25480
P407
P577
2018-05-29T00:00:00Z